Discovery on Target
The annual Discovery on Target (DOT) meeting highlights advances in current and emerging “hot” targets and technologies for discovery, as well as target validation strategies for development of novel therapeutic agents, ranging from biologics to small molecules. Due to the ongoing impact of the COVID-19 global pandemic, this year’s conference is going virtual!
We are proud to be supporting the event, and we hope the digital format will be a great success. Our North American Business Development Manager, Nick Brown, will give a talk on target specificity screening of antibodies and related molecules. Both he and colleague Teo Pascu will be available for Q&As and networking discussions throughout the three day event.
Another highlight of the meeting will be a presentation by a recent collaborator from The Scripps Research Institute in Florida:
“Antigen discovery driven by efficient and differential phage display selection of antibody libraries on live cells”
Professor Christoph Rader (time TBC)
For further information and updates on this event please visit the DOT website.